Life Sciences Hub Cambridge

Life Sciences Hub Cambridge
Name	Life Sciences Hub Cambridge
Formation	2018
Headquarters	Cambridge, England
Region served	Cambridgeshire and beyond
Leader title	Chief Executive
Leader name	Elizabeth Hardcastle

Life Sciences Hub Cambridge is a translational and networking organisation based in Cambridge, England that connects biomedical research, clinical practice, and industry. It acts as an intermediary among local and national institutions to accelerate commercialization, catalyse collaboration, and support scale-up of diagnostics, therapeutics, and digital health technologies. The organisation works across academic, clinical, and investment ecosystems to translate discoveries from laboratory to patient care.

History

Life Sciences Hub Cambridge was established in 2018 following regional strategic reviews involving Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, and local enterprise initiatives like Cambridgeshire and Peterborough Combined Authority. Early precedent and inspiration derived from models such as Life Sciences Hub Wales and MaRS Discovery District in Toronto. Initial governance drew representatives from NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, and the Wellcome Trust, aligning with city-scale development plans including Cambridge Biomedical Campus expansion. Milestones included the launch of accelerator programs in 2019, a strategic partnership announcement with Genomics England affiliates in 2020, and participation in pandemic-response consortia alongside Public Health England collaborators.

Mission and Objectives

The Hub’s stated mission emphasizes translation of life science innovation into clinical and commercial impact by supporting entrepreneurs, clinicians, and researchers. Objectives include fostering connectivity among stakeholders such as AstraZeneca, GlaxoSmithKline, and local spinouts from Babraham Institute; enabling access to clinical trials networks including Cancer Research UK initiatives; and promoting workforce development aligned with training providers like Anglia Ruskin University. Strategic aims reference regional growth strategies promoted by entities like Cambridge Ahead and investment frameworks exemplified by UK Research and Innovation.

Facilities and Campuses

Facilities associated with the organisation operate within the Cambridge cluster, leveraging proximity to hubs like Cambridge Biomedical Campus, St John’s Innovation Park, and incubators near Harston Mill. Physical resources include coworking space for startups, meeting rooms connected to Judge Business School networks, and project labs configured for early-stage wet lab work inspired by practices at Milner Therapeutics Institute. The Hub coordinates access to shared infrastructure such as biobanks linked to European Bioinformatics Institute collaborations, and imaging suites adjacent to CRUK Cambridge Centre facilities.

Research and Innovation Programs

Programs span translational acceleration, clinical adoption pathways, and digital health validation. Initiatives have included accelerator cohorts modeled on StartUp Health, translational fellowships similar to Wellcome Leap awards, and challenge programs aligned with Innovate UK competitions. The Hub facilitates interdisciplinary projects that bring together teams from Department of Biochemistry, University of Cambridge, Department of Clinical Neurosciences, and industry partners like Illumina for genomics applications. It supports proof-of-concept studies, clinical evaluation pipelines with involvement from NHS England partners, and regulatory navigation informed by expertise linked to Medicines and Healthcare products Regulatory Agency.

Partnerships and Collaborations

Collaboration is central, with formal links to academic institutions including University of Cambridge, Imperial College London networks, and research institutes such as Babraham Institute and Francis Crick Institute. Clinical partnerships involve Cambridge University Hospitals NHS Foundation Trust and regional Integrated Care Systems. Industry engagement spans multinational firms like AstraZeneca and venture-backed companies from Cambridge Enterprise portfolios. International collaborations reference sister organisations like Life Sciences Hub Wales and ecosystem partners including BioValley and MaRS Discovery District to exchange best practices and co-run translational programs.

Funding and Governance

Funding sources combine public-sector grants, philanthropic contributions, and corporate sponsorship. Grant partners have included UK Research and Innovation, Wellcome Trust, and regional funds administered by Cambridgeshire and Peterborough Combined Authority. Private support has come from corporate sponsors and venture capital firms active in the cluster such as Abingworth and SV Health Investors. Governance is overseen by an independent board drawing members from institutions like Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, and local enterprise groups, with oversight aligned to charity and company law frameworks used by comparable entities such as Royal Society spinouts.

Impact and Achievements

The Hub has catalysed spinouts and clinical collaborations that progressed to series A funding rounds led by investors including Sofinnova Partners and Index Ventures. Its programs supported diagnostic and digital-health pilots that partnered with NHS England pathways and entered evaluation with bodies such as National Institute for Health and Care Excellence. Reported achievements include facilitating cross-sector consortia that secured Innovate UK awards, enabling translational fellowships with placement in Addenbrooke's Hospital wards, and contributing to cluster growth metrics tracked by Cambridge Ahead. The organisation has played a role in strengthening Cambridge’s position within the global life sciences ecosystem alongside peers like Wellcome Sanger Institute and private-sector anchors such as CureVac.

Category:Organisations based in Cambridge